Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Reviews in Medical Virology|June 1, 2011
Rethinking herpes simplex virus: the way to oncolytic agentsGabriella Campadelli-Fiume, Carla De Giovanni, Valentina Gatta, et al.
Current Drug Targets|December 17, 2010
Vaccines and other immunological approaches for cancer immunopreventionPier-Luigi Lollini, Giordano Nicoletti, Lorena Landuzzi, et al.
Gastroenterology Clinics of North America|December 20, 2002
Immunoprevention of colorectal cancer: a future possibility?Pier-Luigi Lollini, Carla De Giovanni, Giordano Nicoletti, et al.
Oncology Reports|July 6, 2007
Expression of a functional CCR7 chemokine receptor inhibits the post-intravasation steps of metastasis in malignant murine mammary cancer cellsStefania Croci, Giordano Nicoletti, Lorena Landuzzi, et al.
European Journal of Cancer (Oxford, England : 1990)|August 22, 2009
APC10.1 cells as a model for assessing the efficacy of potential chemopreventive agents in the Apc(Min) mouse model in vivoStewart Sale, Isabel L Fong, Carla de Giovanni, et al.
Pathology Oncology Research : POR|December 26, 2007
Expression of connective tissue growth factor (CTGF/CCN2) in a mouse model of rhabdomyosarcomagenesisStefania Croci, Lorena Landuzzi, Giordano Nicoletti, et al.
International Journal of Cancer|January 30, 2004
Apc10.1: an ApcMin/+ intestinal cell line with retention of heterozygosityCarla De Giovanni, Lorena Landuzzi, Giordano Nicoletti, et al.
BMC Cancer|February 9, 2019
Immune targeting of autocrine IGF2 hampers rhabdomyosarcoma growth and metastasisCarla De Giovanni, Patrizia Nanni, Lorena Landuzzi, et al.
Vaccine|March 5, 2003
Protein vaccination with the HER2/neu extracellular domain plus anti-HER2/neu antibody-cytokine fusion proteins induces a protective anti-HER2/neu immune response in miceJay S Dela Cruz, Suk Ying Lau, Ernesto M Ramirez, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 22, 2009
Inhibition of human tumor growth in mice by an oncolytic herpes simplex virus designed to target solely HER-2-positive cellsLaura Menotti, Giordano Nicoletti, Valentina Gatta, et al.
Pageof 6